```html

Lithium Toxicity – A Complete Medical Guide

Overview

Lithium toxicity (also called lithium poisoning) occurs when the level of lithium in the blood rises above the therapeutic range and begins to cause harmful effects on the nervous system, kidneys, heart, and other organs. Lithium is a small‑ion mood stabilizer most commonly prescribed for bipolar disorder, but it is also used off‑label for major depression, schizoaffective disorder, and certain neuro‑protective indications.

Who it affects: Anyone taking lithium can develop toxicity, but the risk is higher in:

• Adults with bipolar disorder (the largest prescribing group).
• Elderly patients – reduced kidney function makes lithium clearance slower.
• People with chronic kidney disease (CKD) or heart failure.
• Patients who are dehydrated, have a recent infection, or are taking interacting drugs (e.g., NSAIDs, ACE inhibitors, thiazide diuretics).

Prevalence: In the United States, lithium is prescribed to an estimated 1–2 % of the adult population (≈2–3 million people). Toxic episodes are relatively uncommon when lithium is monitored correctly, occurring in <≈0.5 % of treated patients each year, but they account for a disproportionate share of medication‑related hospitalizations (CDC).

Symptoms

Lithium toxicity is graded by blood concentration, and the clinical picture often mirrors the level.

Mild Toxicity (Serum lithium 1.5–2.0 mmol/L)

• Gastrointestinal: nausea, vomiting, diarrhea, abdominal cramps.
• Neurologic: tremor (fine, rhythmic), mild headache, fatigue, reduced attention.
• Urinary: polyuria (increased urination) due to nephrogenic diabetes insipidus.

Moderate Toxicity (Serum lithium 2.0–2.5 mmol/L)

• Worsening of the above GI symptoms, often with persistent vomiting.
• Neurologic: coarse tremor, ataxia (unsteady gait), dysarthria (slurred speech), myoclonic jerks, confusion, agitation.
• Cardiovascular: sinus tachycardia, mild hypotension.

Severe Toxicity (Serum lithium >2.5 mmol/L)

• Neurologic: seizures, stupor, coma, profound ataxia, nystagmus, extrapyramidal signs (rigidity, Parkinson‑like tremor).
• Cardiac: arrhythmias (e.g., atrial fibrillation, ventricular ectopy), prolonged PR or QT interval.
• Renal: acute kidney injury, oliguria.
• Hyperreflexia, muscle fasciculations, and in extreme cases, permanent neurologic deficits.

Because lithium has a narrow therapeutic index, symptoms may appear suddenly after a change in hydration status, medication regimen, or renal function.

Causes and Risk Factors

Primary Causes

• Over‑dosage: accidental or intentional ingestion of more lithium than prescribed.
• Impaired excretion: reduced glomerular filtration rate (GFR) leading to accumulation.
• Drug interactions: medications that decrease renal clearance or increase reabsorption (e.g., thiazide diuretics, NSAIDs, ACE inhibitors, ARBs, carbamazepine, valproic acid).
• Fluid/electrolyte shifts: dehydration, diarrhea, vomiting, sweating, or high fever can concentrate lithium in the bloodstream.

Risk Factors

• Age > 65 years.
• Baseline chronic kidney disease (eGFR < 60 mL/min/1.73 m²).
• Concurrent use of nephrotoxic or sodium‑depleting drugs.
• Low sodium diet or severe salt restriction (increases lithium reabsorption).
• Poor medication adherence (missed doses followed by a “catch‑up” dose).
• Pregnancy – physiological changes in renal blood flow can alter lithium levels.

Diagnosis

Diagnosis relies on a combination of clinical suspicion, laboratory data, and sometimes imaging.

Laboratory Tests

• Serum lithium level: drawn 12 hours after the last dose (trough level). Therapeutic range = 0.6–1.2 mmol/L; toxicity generally >1.5 mmol/L.
• Renal function panel: serum creatinine, BUN, eGFR.
• Electrolytes: sodium, potassium, calcium, magnesium – abnormalities may influence lithium handling.
• CBC: to assess for anemia or infection that could confound symptoms.

Additional Evaluation

• ECG: indicated in moderate‑to‑severe toxicity to look for arrhythmias or QT changes.
• Neurologic exam: assessment of reflexes, coordination, mental status.
• Urine output monitoring: oliguria suggests renal involvement.
• Imaging (CT/MRI): rarely needed, but performed if seizures or focal neurologic deficits occur to rule out stroke or bleed.

Because lithium levels can fluctuate quickly, repeat serum measurements every 4–6 hours are recommended during acute management (Mayo Clinic).

Treatment Options

General Principles

• Stop lithium immediately.
• Correct dehydration and electrolyte abnormalities.
• Monitor serum lithium every 4 hours until <1.0 mmol/L.
• Provide supportive care (airway protection, seizure control, cardiac monitoring).

Specific Interventions

1. Intravenous Hydration

Isotonic saline (0.9 % NaCl) bolus 1–2 L, followed by maintenance infusion to achieve a urine output of > 2 L/24 h. This enhances renal clearance.

2. Hemodialysis

Indicated for:

• Serum lithium ≥ 4.0 mmol/L (any clinical status) or ≥ 2.5 mmol/L with severe neurologic symptoms.
• Kidney failure (eGFR < 30 mL/min).
• Unresponsive or worsening toxicity despite aggressive hydration.

A single 4‑hour high‑flux dialysis session can remove 60‑80 % of lithium. Post‑dialysis lithium levels are rechecked because rebound may occur as lithium redistributes from tissue stores.

3. Medications

• Seizure control: benzodiazepines (e.g., lorazepam) are first‑line; avoid phenytoin as it may increase lithium levels.
• Arrhythmia management: treat per ACLS guidelines; avoid drugs that further impair renal function.
• Antiemetics: ondansetron or metoclopramide for vomiting.

4. Disposition

Patients with mild toxicity and normal renal function can often be observed in a short‑stay unit. Moderate‑to‑severe cases generally require admission to an intensive care or step‑down unit, especially when dialysis is contemplated.

Long‑Term Management After an Episode

• Re‑evaluate the need for lithium – consider dose reduction or alternative mood stabilizer.
• Establish a strict monitoring schedule (serum lithium and renal labs every 3–6 months; more often after dose changes).
• Educate the patient on fluid and sodium intake, signs of early toxicity, and drug‑interaction risks.

Living with Lithium Toxicity

Daily Management Tips

• Medication schedule: take lithium at the same time each day, preferably with a consistent amount of food and fluid.
• Hydration: aim for > 2 L of fluid per day unless restricted by a physician; carry a water bottle.
• Sodium balance: maintain a moderate sodium diet (≈1500‑2000 mg/day). Avoid extreme low‑salt diets without medical supervision.
• Medication review: keep an up‑to‑date list of all drugs, including over‑the‑counter NSAIDs and herbal supplements; share it with every prescriber.
• Laboratory monitoring: schedule blood tests before starting a new medication, after any illness with fever or vomiting, and at least every 3 months in stable patients.
• Alert system: set phone reminders for labs and refills; consider a wearable device that tracks heart rate and alerts you to sudden changes.

Psychosocial Considerations

Because lithium is often essential for mood stability, abrupt discontinuation can precipitate relapse. Work with a psychiatrist to taper slowly if lithium must be stopped, and implement psychotherapy or alternative pharmacotherapy as needed.

Prevention

• Regular therapeutic drug monitoring (TDM): keep serum lithium within the target range (0.6–1.2 mmol/L). Adjust the dose based on renal function.
• Renal function surveillance: check eGFR at baseline and at least annually; more frequently if > 65 years or if CKD is present.
• Avoid interacting drugs: consult a pharmacist before starting NSAIDs, diuretics, ACE/ARBs, or certain antiepileptics.
• Hydration & diet: maintain adequate fluid intake; avoid drastic sodium restriction or high‑protein, low‑carb “keto” diets that alter lithium handling.
• Patient education: teach the “early warning signs” (tremor, nausea, increased thirst) and when to call a provider.
• Pregnancy planning: discuss risks with an obstetrician‑psychiatrist team; dose adjustments or alternative agents may be warranted.

Complications

If untreated or delayed, lithium toxicity can lead to serious, sometimes permanent, complications:

• Neurologic damage: cerebellar degeneration, persistent ataxia, or Parkinsonian features.
• Renal failure: acute tubular necrosis progressing to chronic kidney disease.
• Cardiac events: life‑threatening arrhythmias or myocardial injury.
• Endocrine disturbances: hypothyroidism (already a known lithium side effect) may worsen.
• Seizure‑related injury: falls, fractures, or status epilepticus.

Long‑term survivors often require multidisciplinary follow‑up (nephrology, cardiology, neurology, psychiatry).

When to Seek Emergency Care

References

• Mayo Clinic. “Lithium: Side Effects & Interactions.” https://www.mayoclinic.org
• U.S. Centers for Disease Control and Prevention. “Medication Errors.” https://www.cdc.gov
• National Institute of Mental Health. “Lithium for Bipolar Disorder.” https://www.nimh.nih.gov
• World Health Organization. “Guidelines for the Management of Toxic Exposures.” 2022.
• Cleveland Clinic. “Lithium Toxicity.” https://my.clevelandclinic.org
• PubMed. “Outcomes of Lithium Overdose and the Role of Hemodialysis.” Journal of Toxicology Clinical Practice, 2021.

```